{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:02:49Z","timestamp":1777518169510,"version":"3.51.4"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T00:00:00Z","timestamp":1465257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM100784"],"award-info":[{"award-number":["R01 GM100784"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 OD010423"],"award-info":[{"award-number":["T32 OD010423"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156000","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T13:33:30Z","timestamp":1465306410000},"page":"e0156000","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide Antimicrobials"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-5075","authenticated-orcid":true,"given":"Jennifer M.","family":"Reinhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Motsinger-Reif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Yale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Trepanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijantimicag.2008.09.010","article-title":"Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence","volume":"33","author":"SG Avgeri","year":"2009","journal-title":"Int J Antimicrob Ag"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pop.2008.01.001","article-title":"Urinary tract infections","volume":"35","author":"DM Drekonja","year":"2008","journal-title":"Prim Care"},{"issue":"1","key":"ref3","first-page":"60","article-title":"Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: meta-analysis of randomized controlled trials","volume":"55","author":"IP Korbila","year":"2009","journal-title":"Can Fam Physician"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2008.10.001","article-title":"Treatment of non-life-threatening methicillin-resistant <italic>Staphylococcus aureus<\/italic> infections with alternative antimicrobial agents: a 2-year retrospective review","volume":"63","author":"DM Drekonja","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/RHU.0b013e31817a7e30","article-title":"Prophylactic antibiotic usage for <italic>Pneumocystis jirovecii<\/italic> pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature","volume":"14","author":"D Gupta","year":"2008","journal-title":"J Clin Rheumatol"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1086\/383150","article-title":"Failure of low-dose atovaquone prophylaxis against <italic>Pneumocystis jiroveci<\/italic> infection in transplant recipients","volume":"38","author":"M Rodriguez","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06880.x","article-title":"Modern management of chronic granulomatous disease","volume":"140","author":"RA Seger","year":"2008","journal-title":"Br J Haematol"},{"issue":"11\u201312","key":"ref8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/00365540903214256","article-title":"Good outcome with trimethoprim 10 mg\/kg\/day-sulfamethoxazole 50 mg\/kg\/day for <italic>Pneumocystis jirovecii<\/italic> pneumonia in HIV infected patients","volume":"41","author":"M Thomas","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"ref9","first-page":"9","article-title":"Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis","volume":"15","author":"AE Cribb","year":"1996","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-3476(99)70472-5","article-title":"Fixed drug eruptions in children","volume":"134","author":"JG Morelli","year":"1999","journal-title":"J Pediatr"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/0378-6323.42883","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"RM Patel","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1067\/mjd.2001.117854","article-title":"Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype","volume":"45","author":"E Ozkaya-Bayazit","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00000637-198209000-00011","article-title":"Toxic epidermal necrolysis-case report and review of the literature","volume":"9","author":"JE Ortiz","year":"1982","journal-title":"Ann Plast Surg"},{"issue":"3","key":"ref14","first-page":"255","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lom\u00e9, Togo: retrospective study of 89 cases","volume":"70","author":"B Saka","year":"2010","journal-title":"Med Trop (Mars)"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.1995.01690170046006","article-title":"Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants","volume":"131","author":"P Wolkenstein","year":"1995","journal-title":"Arch Dermatol"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9120(00)00146-6","article-title":"A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes","volume":"33","author":"MG Neuman","year":"2000","journal-title":"Clin Biochem"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","article-title":"Differences in Metabolism of Sulfonamides Predisposing to Idiosyncratic Toxicity","volume":"105","author":"NH Shear","year":"1986","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref18","first-page":"21","article-title":"Familial tendency in hypersensitivity reactions to co-trimoxazole","volume":"96","author":"J Mohanasundaram","year":"1998","journal-title":"J Indian Med Assoc"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.1994.tb04401.x","article-title":"N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients","volume":"38","author":"C Delom\u00e9nie","year":"1994","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00008571-200011000-00005","article-title":"Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity","volume":"10","author":"M Pirmohamed","year":"2000","journal-title":"Pharmacogenetics"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.0022-202X.2005.23939.x","article-title":"Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides","volume":"125","author":"P Wolkenstein","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/pgs.09.6","article-title":"TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole","volume":"10","author":"A Alfirevic","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1755-8794-5-32","article-title":"Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV\/AIDS patients","volume":"5","author":"D Wang","year":"2012","journal-title":"BMC Med Genomics"},{"issue":"9\u201310","key":"ref24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s002280050551","article-title":"The arylamine N-acetyltransferase (<italic>NAT2<\/italic>) polymorphism and the risk of adverse reactions to co-trimoxazole in children","volume":"54","author":"E Zieli\u0144ska","year":"1998","journal-title":"E J Clin Pharmacol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199508000-00011","article-title":"A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"P Wolkenstein","year":"1995","journal-title":"Pharmacogenetics"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/FPC.0b013e328357a735","article-title":"Evaluation of polymorphisms in the sulfonamide detoxification genes <italic>NAT2<\/italic>, <italic>CYB5A<\/italic>, and <italic>CYB5R3<\/italic> in patients with sulfonamide hypersensitivity","volume":"22","author":"JC Sacco","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00008571-199902000-00007","article-title":"The effect of genetic polymorphisms in <italic>CYP2C9<\/italic> on sulphamethoxazole N-hydroxylation","volume":"9","author":"HJ Gill","year":"1999","journal-title":"Pharmacogenetics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00403-003-0446-z","article-title":"Glutathione S-transferase polymorphisms in patients with drug eruption","volume":"295","author":"NA Ate\u015f","year":"2004","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"AK Daly","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/tpj.2013.3","article-title":"Genome-wide association analyses suggest <italic>NELL1<\/italic> influences adverse metabolic response to HCTZ in African Americans","volume":"14","author":"JL Del-Aguila","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"MI Lucena","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"<italic>SLCO1B1<\/italic> variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"E Link","year":"2008","journal-title":"N Engl J Med"},{"key":"ref33","first-page":"1049","article-title":"Electronic medical record embedded functions facilitate attending-trainee care oversight and education","author":"GA McCarty","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0161-5890(88)90050-8","article-title":"Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole","volume":"25","author":"DG Harle","year":"1988","journal-title":"Mol Immunol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0091-6749(91)90186-R","article-title":"Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine","volume":"88","author":"RS Gruchalla","year":"1991","journal-title":"J Allergy Clin Immun"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"CA Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gepi.20516","article-title":"Quality control and quality assurance in genotypic data for genome-wide association studies","volume":"34","author":"CC Laurie","year":"2010","journal-title":"Genet Epidemiol"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/1471-2105-14-369","article-title":"A comparison study of succinct data structures for use in GWAS","volume":"14","author":"PP Putnam","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-07-5733","article-title":"Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas","volume":"68","author":"D Azzopardi","year":"2008","journal-title":"Cancer Res"},{"issue":"5685","key":"ref41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1099870","article-title":"Multiple rare alleles contribute to low plasma levels of HDL cholesterol","volume":"305","author":"JC Cohen","year":"2004","journal-title":"Science"},{"issue":"5875","key":"ref42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1155174","article-title":"Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia","volume":"320","author":"T Walsh","year":"2008","journal-title":"Science"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajhg.2008.06.024","article-title":"Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data","volume":"83","author":"B Li","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2014.06.009","article-title":"Rare-variant association analysis: study designs and statistical tests","volume":"95","author":"S Lee","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajhg.2011.05.029","article-title":"Rare-variant association testing for sequencing data with the sequence kernel association test","volume":"89","author":"MC Wu","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/biostatistics\/kxs014","article-title":"Optimal tests for rare variant effects in sequencing association studies","volume":"13","author":"S Lee","year":"2012","journal-title":"Biostatistics"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1467-842X.1961.tb00058.x","article-title":"The combination of probabilities: an application of orthonormal functions","volume":"3","author":"HO Lancaster","year":"1961","journal-title":"Aust J Stat"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"R Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0091-6749(99)70243-5","article-title":"Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs","volume":"103","author":"J Quiralte","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"SI Hung","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"9308","key":"ref51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"S Mallal","year":"2002","journal-title":"Lancet"},{"issue":"6982","key":"ref52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"WH Chung","year":"2004","journal-title":"Nature"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10549-010-1034-5","article-title":"Association of <italic>CYP1B1<\/italic> with hypersensitivity induced by taxane therapy in breast cancer patients","volume":"124","author":"R Rizzo","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s004200000159","article-title":"Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization","volume":"73","author":"GA Westphal","year":"2000","journal-title":"Int Arch Occup Environ Health"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000433","article-title":"A genome-wide association study confirms <italic>VKORC1<\/italic>, <italic>CYP2C9<\/italic>, and <italic>CYP4F2<\/italic> as principal genetic determinants of warfarin dose","volume":"5","author":"F Takeuchi","year":"2009","journal-title":"PLoS Genet"},{"key":"ref56","unstructured":"Ziagen [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2008."},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/tpj.2008.4","article-title":"Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions","volume":"9","author":"MR Nelson","year":"2009","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/bfgp\/elu036","article-title":"An overview of SNP interactions in genome-wide association studies","volume":"14","author":"P Li","year":"2015","journal-title":"Brief Funct Genomics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12863-016-0331-3","article-title":"A powerful score-based test statistic for detecting gene-gene co-association","volume":"17","author":"J Xu","year":"2016","journal-title":"BMC Genet"},{"issue":"9","key":"ref60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tig.2014.07.004","article-title":"Functional and genomic context in pathway analysis of GWAS data","volume":"30","author":"MA Mooney","year":"2014","journal-title":"Trends Genet"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2174\/138161208786369731","article-title":"Provocation tests in diagnosing drug hypersensitivity","volume":"14","author":"PJ Bousquet","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-110-4-286","article-title":"Diagnosis of sulfonamide hypersensitivity reactions by <italic>in vitro<\/italic> rechallenge with hydroxylamine metabolites","volume":"110","author":"MJ Rieder","year":"1989","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0006-2952(97)00547-9","article-title":"Comparison of the <italic>in vitro<\/italic> cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone","volume":"55","author":"TP Reilly","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"SH Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1083\/jcb.130.4.1005","article-title":"Large and small splice variants of collagen XII: differential expression and ligand binding","volume":"130","author":"M Koch","year":"1995","journal-title":"J Cell Biol"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/hmg\/ddt637","article-title":"Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy","volume":"23","author":"D Hicks","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","article-title":"GCTA: a tool for Genome-wide complex trait analysis","volume":"88","author":"J Yang","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/FPC.0b013e32833d7b45","article-title":"Genome-wide association studies in pharmacogenomics: successes and lessons","volume":"23","author":"AA Motsinger-Reif","year":"2013","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome","volume":"100","author":"FM Gordin","year":"1984","journal-title":"Ann Intern Med"},{"issue":"7","key":"ref70","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02599836","article-title":"Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary <italic>Pneumocystis carinii<\/italic> pneumonia prophylaxis","volume":"10","author":"S Hennessy","year":"1995","journal-title":"J Gen Intern Med"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00042560-199812150-00009","article-title":"A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in <italic>Pneumocystis carinii<\/italic> pneumonia prophylaxis (CTN 057)","volume":"19","author":"SL Walmsley","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","article-title":"Oral therapy for <italic>Pneumocystis carinii<\/italic> pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone","volume":"323","author":"I Medina","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/infdis\/167.1.180","article-title":"Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with <italic>Pneumocystis carinii<\/italic> pneumonia and AIDS","volume":"167","author":"A Carr","year":"1993","journal-title":"J Infect Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mjd.2002.120468","article-title":"Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS","volume":"47","author":"M Eliaszewicz","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"ref75","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/003655401317074581","article-title":"Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression","volume":"33","author":"C Rabaud","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"ref76","first-page":"23","article-title":"Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature","volume":"97","author":"C Ryan","year":"1998","journal-title":"Wisc Med J"},{"issue":"2","key":"ref77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000324506","article-title":"Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome","volume":"222","author":"T Hubiche","year":"2011","journal-title":"Dermatology"},{"issue":"2","key":"ref78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2169\/internalmedicine.45.1352","article-title":"Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6","volume":"45","author":"T Morimoto","year":"2006","journal-title":"Int Med"},{"issue":"5","key":"ref79","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.trsl.2012.12.012","article-title":"Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation","volume":"161","author":"MG Neuman","year":"2013","journal-title":"Transl Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T06:24:28Z","timestamp":1568010268000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156000"}},"subtitle":[],"editor":[{"given":"Quan","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156000","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}